首页|期刊导航|中国药业|度拉糖肽联合运动疗法对2型糖尿病大鼠的影响

度拉糖肽联合运动疗法对2型糖尿病大鼠的影响OA

Effects of Dulaglutide Combined with Exercise Therapy on Type 2 Diabetic Rats

中文摘要英文摘要

目的 探讨度拉糖肽联合运动疗法对模型大鼠 2 型糖尿病(T2DM)的改善效果.方法 通过高胆固醇、高脂肪饮食喂饲及腹腔注射链脲佐菌素以复制 T2DM 大鼠模型,将建模成功的 40 只大鼠随机分为模型组、度拉糖肽组(度拉糖肽 1.0mg/kg)、运动疗法组(等体积生理盐水+自主跑步)和联合组(度拉糖肽 1.0mg/kg+自主跑步),另选 10只正常大鼠为对照组(等体积生理盐水).皮下注射相应药物或生理盐水,每天 1 次,持续 4 周.采用血糖仪、血压计分别检测大鼠的血糖和血压水平;Masson 染色法观察大鼠心脏和肾脏组织形态;采用酶比色法检测大鼠血脂水平;采用放射免疫法检测大鼠胰岛素(INS)水平,并计算胰岛素敏感指数(ISI);采用酶联免疫吸附试验法检测脂联素、瘦素和疲劳相关指标.结果 与模型组比较,度拉糖肽组、运动疗法组和联合组大鼠空腹血糖、总胆固醇、甘油三酯水平均显著降低(P<0.05),INS 水平均显著降低、ISI均显著升高(P<0.05);度拉糖肽组、运动疗法组及联合组大鼠收缩压和舒张压均显著降低(P<0.05),脂联素水平均显著升高、瘦素水平均显著降低(P<0.05),一氧化氮合酶,诱导型和原生型一氧化氮合酶水平均显著降低(P<0.05).且联合组指标均较单一治疗组更优.模型组大鼠心肌细胞直径显著大于对照组(P<0.05),度拉糖肽组和运动疗法组显著小于模型组(P<0.05);模型组大鼠肾小球系膜基质增生率显著高于对照组(P<0.05),联合组显著低于度拉糖肽组和运动疗法组(P<0.05).结论 度拉糖肽联合运动疗法可显著降低 T2DM模型大鼠的胰岛素抵抗,改善高血压症状,减轻疲劳程度.

Objective To investigate the improvement effect of dulaglutide combined with exercise therapy on type 2 diabetes mellitus(T2DM)model rats.Methods A T2DM rat model was replicated by feeding high cholesterol,high-fat diet,and intraperitoneal injection of streptozotocin.A total of 40 successfully modeled rats were randomly divided into the model group,dulaglutide group(dulaglutide 1.0 mg/kg),exercise therapy group(equal volume normal saline+autonomous running),and combination group(dulaglutide 1.0 mg/kg+autonomous running).A total of 10 normal rats were selected as the control group(equal volume normal saline).Rats in each group received subcutaneous injection of medication or normal saline once a day for 4 weeks.Blood glucose meter and sphygmomanometer were used to measure the blood glucose and blood pressure levels of rats,respectively.Morphology of the rats'heart and kidney tissues were observed by Masson staining method.Enzyme colorimetric method was used to detect the blood lipid levels;radioimmunoassay was used to detect insulin(INS)levels and insulin sensitivity index(ISI)was calculated;enzyme-linked immunosorbent assay was used to detect adiponectin,leptin,and fatigue related indicators.Results Compared with the model group,the fasting blood glucose,total cholesterol,and triglyceride in the dulaglutide group,exercise therapy group,and combination group were significantly reduced(P<0.05),as well as INS levels were significantly reduced and ISIs were significantly increased(P<0.05);the systolic blood pressure and diastolic blood pressure of rats in the dulaglutide group,exercise therapy group,and combination group were significantly reduced(P<0.05),while adiponectin levels were significantly increased and leptin levels were significantly reduced(P<0.05);the levels of nitric oxide synthase,inducible and native nitric oxide synthase were significantly reduced(P<0.05).Moreover,the indicators in the combination group were better than those in the single-treatment group.The diameter of myocardial cells in the model group was significantly larger than that in the control group(P<0.05),while those in the dulaglutide group and exercise therapy group were significantly smaller than that in the model group(P<0.05).The proliferation rate of glomerular mesangial matrix in the model group was significantly higher than that in the control group(P<0.05),while that in the combination group was significantly lower than that in the dulaglutide group and exercise therapy group(P<0.05).Conclusion Dulaglutide combined with exercise therapy can significantly reduce insulin resistance,improve hypertension symptoms,and alleviate fatigue in T2DM rats.

张慧荣;王婷婷;肖婷婷;石美玲;王磊;宋国增

河北省衡水市第四人民医院,河北 衡水 053000河北省衡水市第四人民医院,河北 衡水 053000河北省衡水市第四人民医院,河北 衡水 053000河北省衡水市第四人民医院,河北 衡水 053000河北省衡水市第四人民医院,河北 衡水 053000河北省衡水市第四人民医院,河北 衡水 053000

医药卫生

度拉糖肽运动疗法2型糖尿病大鼠胰岛素抵抗高血压疲劳

dulaglutideexercise therapytype 2 diabetes mellitusratinsulin resistancehypertensionfatigue

《中国药业》 2026 (18)

43-48,6

河北省衡水市科技计划(自筹经费)项目[2024014080Z].

10.3969/j.issn.1006-4931.2026.18.010

评论